BEIGENE announces that the stock code for American Depositary Shares traded on Nasdaq will change from "BGNE" to "ONC", effective January 2, 2025. This change aims to highlight the company's firm commitment to providing innovative oncology drugs on a Global scale. The stock codes and abbreviations for the Shanghai Stock Exchange and Hong Kong Stock Exchange will remain unchanged. The change in Nasdaq stock code can be implemented without submission for a Shareholder meeting review. The company will fulfill its information disclosure obligations timely based on the progress of relevant matters.